Last week, the company announced a $225 million settlement with the Department of Justice for civil and criminal investigations into illegal promotion of the cancer pain drug Subsys.
The conviction of John Kapoor and others from Insys Therapeutics represents the first successful prosecution of pharmaceutical executives for crimes related to the opioid crisis, US District Attorney Andrew Lelling said.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
The outgoing commissioner requested $55 million to aid the agency's fight against the opioid epidemic.